Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients.
about
Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@ast
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@en
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@nl
type
label
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@ast
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@en
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@nl
prefLabel
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@ast
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@en
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@nl
P2093
P50
P356
P1476
Potential implications of CYP3 ...... monotherapy in HIV-1 patients.
@en
P2093
Giulia Berno
Leopoldo Paolo Pucillo
Luigia Pucci
Massimo Tempestilli
Mauro Zaccarelli
Roberta D'Arrigo
P356
10.7448/IAS.17.4.19589
P433
P577
2014-11-02T00:00:00Z